Non-alcoholic fatty liver disease and dyslipidemia: An update.
about
Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone RegulationThe measurement of liver fat from single-energy quantitative computed tomography scans.Therapeutic application of GPR119 ligands in metabolic disorders.Therapies in non-alcoholic steatohepatitis (NASH).Cardiovascular disease prevention strategies for type 2 diabetes mellitus.Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling PathwayFive gene variants in nonagenarians, centenarians and average individuals.Acute aflatoxin B1 - Induced hepatotoxicity alters gene expression and disrupts lipid and lipoprotein metabolism in rats.Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes.Vildagliptin: any effect on non-alcoholic fatty liver disease and serum uric acid? Re: Shelbaya S, Rakha S. Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt - results from the GUARD study.Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model.Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats.Dyslipidaemia in the elderly: to treat or not to treat?Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression.The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients.Zanthoxylum ailanthoides Suppresses Oleic Acid-Induced Lipid Accumulation through an Activation of LKB1/AMPK Pathway in HepG2 Cells.Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease.Drug therapy for ectopic fat: myth or reality?Capsaicin in Metabolic Syndrome.Key Inflammatory Processes in Human NASH Are Reflected in Ldlr-/-.Leiden Mice: A Translational Gene Profiling Study.Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.Association of Lipoprotein-Associated Phospholipase A2 with the Prevalence of Nonalcoholic Fatty Liver Disease: A Result from the APAC Study.Hepatoprotective and Antioxidant Activities of Oil from Baru Almonds ( Vog.) in a Preclinical Model of Lipotoxicity and DyslipidemiaThe impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
P2860
Q37698862-1D26593E-64E9-4432-BECE-69821FED381AQ38622765-315709A8-F232-47DD-9902-9B8434C0AB76Q38655382-FF9E9761-0615-43DB-8A85-F0D443462CBAQ38774861-FBAD8745-61D7-4455-AF8F-E066810BD28EQ39420208-09670652-A530-493F-84EA-8BEEEE1E2718Q41432002-CBAD90DF-1BA3-4FCC-887C-63460EFE565EQ41549644-9C433639-731C-45D3-8AF3-8FC1395654DCQ41678864-848DD820-FF3A-4471-9FBF-BF44A003AA2AQ42700513-154D5348-0EB3-4C4F-8B2D-C6D32D2EF8D3Q46268603-60F02C45-FBC2-41FD-94C7-91E7B7FC9023Q46357255-9D8D4ABD-775B-454B-910A-A17A9816936FQ47128868-318649E3-B2E8-492B-908B-7CC2179E7DD6Q49810183-38CDA020-E109-4F2F-BA10-273FFCD148F8Q50180407-CD032B48-F244-4DFB-842E-8FA576D2605BQ50455460-1AEDA8A0-9F90-4AE1-A6F4-AED148C28577Q51266115-BA704638-201E-49E5-9F1E-62D55E04FF3BQ51744136-9AA7F83B-B0A3-4BC9-97A2-DA8857E37F15Q52584886-E4347122-6CDC-4632-8698-EDDCA94E0EC4Q53707823-7A483BC2-CDED-4486-AAAC-6EC62CB48576Q54978856-BB0027B4-7BEE-48FB-AFA8-F3F0D3E882E0Q55071759-01CC7593-355B-4AD2-BA70-D4DACFADA4BAQ55379918-3BCE2D57-D28D-4A91-956F-3DE92DA04A31Q55526978-3973E9CA-66E7-40C4-A852-A6421E0B77D7Q58123798-E9A0A49A-C74F-4E04-A4BE-D211A18BCD6EQ58786857-A3239037-BEB8-456F-BB5A-38505572F1B4
P2860
Non-alcoholic fatty liver disease and dyslipidemia: An update.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Non-alcoholic fatty liver disease and dyslipidemia: An update.
@en
type
label
Non-alcoholic fatty liver disease and dyslipidemia: An update.
@en
prefLabel
Non-alcoholic fatty liver disease and dyslipidemia: An update.
@en
P1433
P1476
Non-alcoholic fatty liver disease and dyslipidemia: An update.
@en
P2093
Christos S Mantzoros
Niki Katsiki
P304
P356
10.1016/J.METABOL.2016.05.003
P577
2016-05-13T00:00:00Z